1 February 2019 in Acta Medica Portuguesa
Introdução: A presença de múltiplas doenças crónicas, em simultâneo, no mesmo indivíduo é um problema de saúde reconhecido. Os doentes com multimorbilidade têm necessidades de saúde acrescidas, o que representa um ónus elevado para os cuidados de saúde. Embora não exista uma definição consensual do conceito, a multimorbilidade é definida habitualmente pela presença de duas ou mais doenças crónicas. A existência de evidência, para a realidade nacional, quanto à multimorbilidade poderá contribuir para a gestão e tratamento destes doentes de forma mais eficiente.Material e Métodos: Com o objetivo de estimar a prevalência de multimorbilidade e identificar os fatores associados foi realizado um estudo epidemiológico transversal com base nos dados do INSEF, um inquérito de base populacional desenvolvido com uma amostra probabilística representativa da população portuguesa (n = 4911). A prevalência de multimorbilidade foi estimada para o total da população e para cada um dos sexos, estratificada por grupo etário, região de saúde, educação e rendimento. As magnitudes das associações foram medidas pelas razões de prevalências ajustadas calculadas pelo modelo de regressão de Poisson.Resultados: A prevalência de multimorbilidade foi de 38,3% (IC 95%: 35,4% a 41,3%), com maior frequência nas mulheres, nos indivíduos mais velhos, nas regiões de Lisboa e Vale do Tejo, Norte, Algarve e Alentejo e em níveis educacionais mais baixos. Não foi observada associação estatisticamente significativa entre a multimorbilidade e o rendimento.Discussão: A multimorbilidade é um problema que afeta mais de um terço da população portuguesa. O conhecimento epidemiológico sobre a multimorbilidade em Portugal permite identificar os grupos populacionais onde esta realidade é mais prevalente. Conclusão: Os valores observados apontam para maior risco de multimorbilidade entre os indivíduos mais velhos e menos diferenciados e está em consonância com os resultados da literatura. Estes dados demonstram a relevância dos doentes com multimorbilidade e têm especial importância na forma com os cuidados de saúde são organizados e prestados.
25 June 2019 in European Journal of Public Health
The existence of multiple chronic conditions in the same patient is a public health problem increasingly recognized as relevant to health systems. Individuals with multimorbidity have additional health needs, which imply a heavy burden in healthcare use. It is estimated that between 70% and 80% of the total health expenditure is used with chronic conditions. Patients with multimorbidity are responsible for up to 75% of primary care appointments. These patients are also high hospital users, with up to 14.6 times more risk of hospitalization. This study analyses the association between healthcare use and multimorbidity in the Portuguese population aged 25-74 years old. The association between socioeconomic variables and healthcare use was studied, based on data from the first Portuguese Health Examination Survey using a logistic regression model, stratified by sex and adjusted for socioeconomic confounding variables. In patients with multimorbidity, there was a greater use of primary healthcare consultations, medical or surgical specialist consultations and hospitalizations. An association was established between female, older age groups and lower educational levels, and increased healthcare use. When adjusted to socioeconomic variables, the likelihood of using healthcare services can be as high as 3.5 times, when compared to patients without chronic conditions. Our results show a greater healthcare use in multimorbidity patients, both in primary and hospital care. The availability of scientific evidence regarding the use of healthcare services by multimorbidity patients may support health policy changes, which could allow a more efficient management of these patients.
1 November 2019 in European Journal of Public Health
Background: The existence of multiple chronic conditions in the same patient is a public health problem, recognized as relevant to health systems. Individuals with multimorbidity have additional health needs, which in the context of continuous increase of life expectancy, imply a heavy burden to healthcare services. Methods: We analysed the association between healthcare use (primary care, medical specialist consultations and hospitalizations) and multimorbidity in the Portuguese population aged 25-74 years old, using the Health Examination Survey (n = 4911) data. Logistic regression models adjusted for predisposing (age, education) and enabling (income, region of residence) factors were fitted separately for male and female. Odds ratios and CI95% were estimated. Results: Prevalence of multimorbidity was 38.3% (95%CI: 35.4%; 41.3%). In males, after adjustment for confounding and when compared to patients without chronic conditions, multimorbidity was associated with greater use of primary care (OR = 3.7; CI95%: 2.3-5.8), medical specialist consultations (OR = 1.9; CI95%: 1.1-3.4) and hospitalizations (OR = 1.8; CI95%: 1.2-2.7). In female, statistically significant association between multimorbidity and healthcare use was observed for primary care (OR = 2.6; CI95%: 1.6-4.3) and medical specialist consultations (OR = 2.8; CI95%: 2.0-3.9), but not for hospitalizations. Both male and female with multimorbidity reported greater use of primary care, compared to individuals with only one chronic condition (OR = 2.4; CI95%: 1.3-4.4 and OR = 1.7; CI95%: 1.1-2.8, respectively). Conclusions: Our results show a greater healthcare use in patients with multimorbidity, both in primary and hospital care. The availability of scientific evidence regarding the healthcare use, by patients with multimorbidity, may substantiate the discussion about the possible need for the Portuguese health system to adapt to these patients, with changes in policies that will allow better and more efficient treatment. Key messages: This study may support the discussion about the adaptation of Portuguese health system to patitents with multimorbidity. Further discussion on policy change is needed, targeting an efficient management of these patients.